Qingqing Cao Selected Research

Autoimmune Diseases (Autoimmune Disease)

11/2017

1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingqing Cao Research Topics

Disease

5	Epilepsy (Aura) 01/2016 - 01/2012
4	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 03/2024 - 01/2019
4	Seizures (Absence Seizure) 01/2016 - 07/2013
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 10/2017
2	Fibrosis (Cirrhosis) 03/2024 - 01/2019
2	Temporal Lobe Epilepsy 12/2015 - 10/2014
1	Hypertension (High Blood Pressure) 06/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2024
1	Pruritus (Itching) 03/2024
1	Alopecia (Baldness) 03/2024
1	Weight Gain 03/2024
1	Skin Diseases (Skin Disease) 03/2024
1	Hemorrhage 01/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023
1	Inappropriate ADH Syndrome (SIADH) 03/2022
1	Hyponatremia 03/2022
1	Neoplasms (Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Pathologic Processes 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Wounds and Injuries (Trauma) 05/2021
1	Overweight 03/2019
1	Multiple Sclerosis 11/2017
1	Autoimmune Diseases (Autoimmune Disease) 11/2017
1	Wolf-Hirschhorn Syndrome 10/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2014
1	Cognitive Dysfunction 07/2013
1	Mental Disorders (Mental Disorder) 07/2013
1	Human Influenza (Influenza) 01/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2022 - 07/2013
4	Pilocarpine (Ocusert)FDA LinkGeneric 01/2016 - 07/2013
2	Collagen Type VIIIBA 03/2024 - 05/2021
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2020 - 11/2017
2	Acid Sensing Ion ChannelsIBA 01/2016 - 01/2016
2	Pentylenetetrazole (Metrazol)IBA 01/2016 - 12/2015
1	SodiumIBA 06/2024
1	Antiviral Agents (Antivirals)IBA 03/2024
1	daclatasvirIBA 03/2024
1	Inosine Triphosphate (ITP)IBA 01/2023
1	GlucocorticoidsIBA 01/2023
1	Vasopressins (Vasopressin)IBA 03/2022
1	AlbuminsIBA 03/2022
1	SaltsIBA 03/2022
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Collagen Type XIIIBA 01/2022
1	2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA 03/2019
1	CollagenIBA 01/2019
1	Fibrillar CollagensIBA 01/2019
1	C.I. direct red 80IBA 01/2019
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2015
1	Phosphotransferases (Kinase)IBA 12/2015
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2015
1	picropodophyllinIBA 12/2015
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2014
1	NigericinIBA 10/2014
1	Messenger RNA (mRNA)IBA 07/2013
1	RNA (Ribonucleic Acid)IBA 01/2012
1	Delayed-Action PreparationsIBA 01/2012
1	Topiramate (Topamax)FDA LinkGeneric 01/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2012

Therapy/Procedure

2	Therapeutics 01/2022 - 10/2017
1	Immunotherapy 11/2017